account_id none on file
legal_name CervoMed Inc.
ticker CRVO
cik 1053691
domain cervomed.com
linkedin_company_url https://www.linkedin.com/company/cervomed/
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Boston, MA, United States
sector index/company/sector/health-care/
calls 0 filings 7 executives 7 family 0
why_nownone on file
callsnone on file
filings
If the Company is unable to raise sufficient capital when needed, it may need to delay, reduce or terminate planned activities to reduce costs, including development or commercialization activities for neflamapimod.
filing / Aug 7, 2026 / receipt
The Company has a short-term lease for office space in Boston, Massachusetts. Lease expense was approximately $ 43,200 and $ 19,660 for the six months ended June 30, 2026 and 2025, respectively.
filing / Aug 7, 2026 / receipt
The aggregate decrease of $0.9 million was primarily due to a $0.6 million decrease in personnel costs primarily driven by lower headcount in the current year period and severance costs in the prior year period, a $0.1 million decrease in professional fees driven by reduced legal expenses for patent work, other corporate legal expenses, and consulting expenses, and a $0.2 million decrease in stock-based compensation
filing / Aug 7, 2026 / receipt
The aggregate decrease of $0.3 million was primarily due to a $0.4 million decrease in personnel costs primarily driven by lower headcount in the current year period and severance costs in the prior year period and a $0.2 million decrease in stock-based compensation, partially offset by a $0.2 million increase in professional fees driven by legal expenses for patent work, other corporate legal expenses, and consultin
filing / Aug 7, 2026 / receipt
If the Company is unable to raise sufficient capital when needed, it may need to delay, reduce or terminate planned activities to reduce costs, including development or commercialization activities for neflamapimod.
filing / May 15, 2026 / receipt
The Company has a short-term lease for office space in Boston, Massachusetts. Lease expense was approximately $ 21,600 and $ 8,500 for the three months ended March 31, 2026 and 2025, respectively.
filing / May 15, 2026 / receipt
The aggregate increase of $0.6 million was primarily due to a $0.4 million increase in professional fees, driven by legal expenses and consulting expenses, and a $0.2 million increase in personnel costs, primarily driven by increased headcount.
filing / May 15, 2026 / receipt
executives
| David Quigley | director | - | receipt |
| Isaac Blech | director | - | receipt |
| Jill Davidson | director | - | receipt |
| Phillip B. Donenberg | Chief Financial Officer | - | receipt |
| Stephen M. Simes | Chief Executive Officer | - | receipt |
| William Elder | Chief Financial Officer & General Counsel | receipt | |
| William Hornung | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-06 | earnings call | scheduled | ir |
changes
| 2025-10-29 | director, appointed | sec_8k |
| 2024-05-20 | Chief Financial Officer, appointed | sec_8k |
| 2023-08-17 | Principal Financial Officer, departed | sec_8k |
| 2023-07-31 | director, appointed | sec_8k |
| 2018-09-27 | Chief Financial Officer, appointed | sec_8k |
| 2016-08-16 | director, appointed | sec_8k |
| 2014-07-09 | director, departed | sec_8k |
| 2014-05-30 | Chief Financial Officer, appointed | sec_8k |
| 2014-03-10 | Chief Executive Officer, appointed | sec_8k |
| 2013-12-16 | director, departed | sec_8k |
| 2013-11-01 | Chairman of the Board, departed | sec_8k |
| 2012-06-29 | Chairman of the Board, departed | sec_8k |
mcp_package_hint
slug cervomed-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$